IMC Chicago’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-47,531
Closed -$568K 6656
2026
Q1
$285K Buy
+47,531
New +$358K ﹤0.01% 4652
2025
Q2
Sell
-27,964
Closed -$288K 3504
2025
Q1
$416K Sell
27,964
-59,230
-68% -$911K ﹤0.01% 2767
2024
Q4
$1.3M Buy
+87,194
New +$1.42M ﹤0.01% 2179
2024
Q2
Sell
-12,950
Closed -$257K 2736
2024
Q1
$243K Buy
+12,950
New +$222K ﹤0.01% 2288

Other funds holding OGN

IMC Chicago's OGN Position: Q2 2026 in Review

IMC Chicago sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 47,531 shares — an estimated $568K sold.

IMC Chicago first reported a position in OGN in Q1 2024 and held it in 4 quarters. The position peaked at $1.3M in Q4 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • IMC Chicago reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 47,531 Organon & Co shares in Q2 2026, an estimated $568K.
  • IMC Chicago first reported a position in Organon & Co in Q1 2024 and held it in 4 quarters.
  • IMC Chicago's Organon & Co position peaked at $1.3M in Q4 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.